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2 
Abstract. By the end of 2004, the Canadian swine population had experienced a severe 1 
increase in the incidence of Porcine circovirus-associated disease (PCVAD), a problem that was 2 
associated with the emergence of a new Porcine circovirus-2 genotype (PCV-2b), previously 3 
unrecovered in North America. Thus it became important to develop a diagnostic tool that could 4 
differentiate between the old and new circulating genotypes (PCV-2a and -2b, respectively). 5 
Consequently, a multiplex real-time quantitative polymerase chain reaction (mrtqPCR) assay that 6 
could sensitively and specifically identify and differentiate PCV-2 genotypes was developed. A 7 
retrospective epidemiological survey that used the mrtqPCR assay was performed to determine if 8 
cofactors could affect the risk of PCVAD. From 121 PCV-2–positive cases gathered for this 9 
study, 4.13%, 92.56% and 3.31% were positive for PCV-2a, PCV-2b, and both genotypes, 10 
respectively. In a data analysis using univariate logistic regressions, PCVAD compatible 11 
(PCVAD/c) score was significantly associated with the presence of Porcine reproductive and 12 
respiratory syndrome virus (PRRSV), PRRSV viral load, PCV-2 viral load, and PCV-2 13 
immunohistochemistry (IHC) results. Polytomous logistic regression analysis revealed that 14 
PCVAD/c score was affected by PCV-2 viral load (P = 0.0161) and IHC (P = 0.0128), but not by 15 
the PRRSV variables (P > 0.9); suggesting that mrtqPCR in tissue is a reliable alternative to IHC. 16 
Logistic regression analyses revealed that PCV-2 increased the odds ratio of isolating 2 major 17 
swine pathogens of the respiratory tract, Actinobacillus pleuropneumoniae and Streptococcus 18 
suis serotypes 1/2, 1, 2, 3, 4, and 7, which are serotypes commonly associated with clinical 19 
diseases. 20 
 21 





Postweaning multisystemic wasting syndrome (PMWS) is a disease of swine initially 2 
identified in Canada in 1991.13 Now, it is known as a worldwide disease with outbreaks reported 3 
in swine herds of North and South America, Europe, and Asia.7 The disease affects 5- to 12-4 
week-old piglets and is characterized in part by weight loss, dyspnea, jaundice, and enlarged 5 
lymph nodes, as well as by degeneration and necrosis of hepatocytes, multifocal 6 
lymphohistiocytic pneumonia, lymphocytic depletion, and multinucleated giant cell formation.26 7 
The etiological agent responsible for PMWS has been identified as a circovirus particle named 8 
Porcine circovirus-2 (PCV-2; family Circoviridae, genus Circovirus).1,19,25 PCV-2 is a small 9 
nonenveloped virus that possesses a single-stranded ambisense circular DNA genome of about 10 
1.76 kb in length.20,33,41,54 Viral DNA possesses at least 3 functional open reading frames 11 
(ORFs): ORF1 encodes the Rep proteins involved in virus replication,9,10,38 ORF2 encodes the 12 
nucleocapsid (Cap) protein,42 and ORF3 encodes a protein that induces apoptosis and is involved 13 
in viral pathogenesis in vivo.35,36 Today, the clinical expression of PCV-2 infection in swine is 14 
acknowledged to be more complex than initially established because it can play a pivotal role in 15 
several syndromes, such as porcine dermatitis and nephropathy syndrome (PDNS), porcine 16 
respiratory disease complex (PRDC), reproductive failure, granulomatous enteritis, necrotizing 17 
lymphadenitis, exudative epidermitis, and congenital tremor.8,27 Consequently, the term “Porcine 18 
circovirus-associated disease (PCVAD)” is now accepted to describe the syndromes in which 19 
PCV-2 plays a role. 20 
At the end of 2004, the swine industry in the province of Québec in Canada started to 21 
experience a significant increase in death rate related to PCVAD.14 It was hypothesized that this 22 
emerging problem was caused by the presence of a new type of circulating PCV-2 strain. This 23 
4 
was confirmed by the sequencing of the entire genome of several PCV-2 strains originating from 1 
PMWS-affected herds.23 Interestingly, this newly recovered PCV-2 genotype (named PCV-2b in 2 
comparison with the circulating genotype named PCV-2a) had already been reported in Asia and 3 
Europe15 and had also been recently reported in the United States.11,30  4 
The current international consensus is that there are at least 2 major PCV-2 genotypes 5 
that are presently circulating worldwide.11,17,23,24,43 It is noteworthy that different nomenclatures 6 
have been used to identify the PCV-2 genotypes: for instance, the PCV-2b and -2a genotypes23 7 
respectively correspond to the restriction fragment length polymorphism (RFLP) classification 8 
321 and 422,6, and to the genotypes 1 and 2.24 Based on RFLP and gene sequence comparison 9 
results, PCV-2b was suggested to be associated with the mortality rate increase observed in 10 
several Canadian swine herds.6 Consequently, even if no experiment confirms yet if the PCV-2b 11 
strains found in Canada are more virulent than previously circulating PCV-2a strains, it became 12 
important to develop a low cost (compared to entire viral genome sequencing) diagnostic test 13 
that could rapidly and efficiently differentiate both genotypes. Previous results indicated that the 14 
protein that best distinguishes PCV-2a from PCV-2b was the Cap protein, with an amino acids 15 
(aa) sequence identity varying from 88–94% between both genotypes.23 Therefore, a new 16 
multiplex real-time quantitative polymerase chain reaction (mrtqPCR) assay was developed to 17 
detect with high sensitivity PCV-2 strains present in tissue samples of pigs. Furthermore, this 18 
new PCR assay was able to identify PCV-2 genotypes by targeting the ORF2 gene. Afterwards, a 19 
retrospective epidemiological survey was conducted using PCV-2 mrtqPCR positive cases that 20 
were submitted at the molecular diagnostic laboratory of the Faculté de médecine vétérinaire 21 
(FMV) of the University of Montreal to determine the prevalence of PCV-2 genotypes; and to 22 
establish if other viral or bacterial pathogens were associated with the clinical disease. 23 
5 
Furthermore, since PCV-2 antigen detection in microscopic lesions by immunohistochemistry 1 
(IHC) is one of the three criteria used for the diagnostic of PCVAD cases,51 the survey was 2 
conducted to determine the relationship between the PCV-2 IHC results and the PCV-2 viral load 3 
with PCVAD. 4 
 5 
Materials and methods 6 
Organisms and culture methods 7 
All bacteria and viruses used as controls were isolated and characterized at the FMV. The 8 
PCV-2 viruses, IAF 2897 (genotype PCV-2a) and FMV-06-1717 (genotype PCV-2b), used in the 9 
mrtqPCR assay were previously characterized reference strains.23 Those viruses were propagated 10 
into PK15A cells, a subclone of PCV noninfected PK15 cells,49 and the viruses were purified 11 
following a 4-hr period of ultracentrifugation on a 30% sucrose cushion using the SW28 12 
Beckman Coulter rotora at 83,000 relative centrifugal force (rcf). The virus pellets were 13 
resuspended in 2 mL of a phosphate buffered saline (PBS) containing 2% fetal bovine serum, 14 
and aliquots of the virus stocks were then conserved at –70°C for future use. The infectious dose 15 
of the virus stock was calculated from a 96-well microplate of PK15A-infected cells following 16 
fluorescent antibody test49 by the Kärber method.47 Virus titers were expressed in tissue culture 17 
infectious dose 50 per mL (TCID50/mL). 18 
Porcine circovirus-2 recombinant plasmids 19 
Extraction of PCV-2 IAF2897 and FMV-06-1717 isolates of DNA was performed using 20 
the Qiagen QIAamp DNA Mini Kitb according to the manufacturer’s instructions. The PCR 21 
products encompassing the entire viral genome of both strains were produced using the 22 
following primers: Fw-SacII-PCV2 (GAACCGCGGGCTGGCTGAACTTTTGAAAGT) and 23 
6 
Rv-SacII-PCV2 (GCACCGCGGAAATTTCTGACAAACGTTACA). The PCR products were 1 
subsequently cloned in the plasmidic vector pCR2.1 using the TA (Taq-amplified) Cloning Kitc 2 
according to the manufacturer’s instructions. Finally, the recombinant plasmids (pCR2.1/PCV-2a 3 
and pCR2.1/PCV-2b) were sequenced to verify the accuracy of the nucleotide sequences and 4 
were used as DNA templates to validate the new mrtqPCR diagnostic assay. 5 
DNA/RNA extraction 6 
Extraction of DNA and RNA from tissue samples (lungs and/or lymph nodes) and virus 7 
isolates was performed using the Qiagen QIAamp DNA Mini Kitb and the Qiagen QIAamp Viral 8 
RNA Mini Kit,b respectively, according to the manufacturer’s instructions. For DNA/RNA tissue 9 
extraction, 100 mg of tissues was put in a 1.5-mL homogenization tube with 0.5-mm glass beads 10 
and 1 mL of PBS. The mix was homogenized at high speed for 3 min in a BeadBeaterd apparatus 11 
and centrifuged for 1 min at 16,100 rcf. DNA was extracted using 200 µl of diluted and 12 
homogenized viral solutions and recombinant plasmid solutions. A volume of 140 µl of diluted 13 
and homogenized viral solution was used for RNA extraction. 14 
Multiplex real-time quantitative polymerase chain reaction assay 15 
Primers and probes were selected within 2 regions of the PCV-2 genome based on 16 
nucleotide alignments generated by the BioEdit Sequence Alignment Editor (version 7.0.5.2)e of 17 
available sequences in public domain databases (over 76 sequences of PCV-2a and -2b strains 18 
were obtained from GenBank and compared) and sequences obtained from viral specimens in the 19 
authors’ molecular diagnostic laboratory (over 49 sequences of PCV-2a and -2b strains).23 For 20 
general detection of PCV-2, a conserved region of PCV-2 genomes was targeted by the mrtqPCR 21 
using the following primers and probe: Circo-Gen-F (GGCCACCTGGGTGTGGTAAA), Circo-22 
Gen-R (CCCACCACTTGTTTCTAGGTGGTT), and Circo-Gen-Probe (6-FAM-23 
7 
TTTGCAGACCCGGAAACCACATACTGGA-BHQ-1). For genotyping, a hypervariable region 1 
localized in the ORF2 of the PCV-2 was targeted by the mrtqPCR using the following primers 2 
and probes: Circo-DF (GGGCCAGAATTCAACCTTAA), Circo-DR 3 
(CGCACCTTCGGATATACTATCA), Circo-2a-Probe (Cy5-4 
GGGGACCAACAAAATCTCTATACCCTTT-BHQ-2), and Circo-2b-Probe (Cy3-5 
GGGCTCAAACCCCCGCTCTGTGCCCTTT-BHQ-2). 6 
In the multiplex reaction, 5 µl of sample containing the DNA template was added to a 20-7 
µl reaction mixture (4.8 µl of LightCycler FastStart DNA MasterPLUS HybProbes,f 400 nM of 8 
each primer and genotyping probes, and 120 nM of Circo-Gen-Probe). Thermocycling and 9 
detection were performed in a SmartCycler 6400 System.g The PCR reaction started with an 10 
initial denaturation and polymerase-activating step of 95°C for 10 min, followed by 45 11 
amplification cycles of a 3-step PCR (95°C for 30 sec; 60°C for 60 sec; and 72°C for 60 sec). 12 
To assess the sensitivity and specificity of the mrtqPCR assay and to determine its ability 13 
to differentiate the 2 PCV-2 genotypes, 10-fold serial dilutions of PCV-2a and -2b reference 14 
viruses and PCV-2 recombinant plasmids (pCR2.1/PCV-2a and pCR2.1/PCV-2b) described 15 
above were assayed. The viruses and recombinant plasmids were then quantified by mrtqPCR. 16 
Furthermore, validation of the mrtqPCR PCV-2 genotype classification from clinical submitted 17 
samples was confirmed following sequencing of 49 PCV-2–positive cases (10 PCV-2a and 39 18 
PCV-2b cases). A conventional multiplex PCR amplification (mPCR) for the detection of type 1 19 
and 2 circoviruses was also performed as previously described.46 The specificities of the primer-20 
probe sets were determined by testing several specimens from different animals, bacterial DNA, 21 
and nucleic acids of swine viruses. The samples consisted of PCV-2–negative porcine tissues, 22 
semen, and sera, as well as bovine tissues, and various pathogens isolated by the FMV diagnostic 23 
8 
laboratory such as Brachyspira hyodysenteriae, Campylobacter spp., Clostridium perfringens, 1 
Enterococcus spp., Escherichia coli, Haemophilus parasuis, Lawsonia intracellularis, 2 
Mycoplasma hyopneumoniae, Pasteurella multocida, Porcine circovirus-1 (PCV-1), Porcine 3 
reproductive and respiratory syndrome virus (PRRSV), Salmonella spp., Staphylococcus hyicus, 4 
Streptococcus suis, swine influenza viruses (SIV) H1N1 and H3N2, and Transmissible 5 
gastroenteritis virus (TGEV). 6 
Retrospective epidemiological survey 7 
Sick or dead pigs that were submitted to and processed by the Institut National de Santé 8 
Animale (INSA), a subsidiary of the Ministère de l’Agriculture, des Pêcheries et de 9 
l’Alimentation du Québec (MAPAQ), were subsequently submitted to the diagnostic services of 10 
FMV. All live animals or carcasses submitted to INSA originated from the province of Quebec 11 
(Québec, Canada). Following necropsy of all submitted animals and evaluation of the gross and 12 
microscopic lesions, several diagnostic tests were realized on tissue samples (such as lung and 13 
lymph nodes) including standard bacteriological identification, PCR identification of viruses and 14 
bacteria, and PCV-2 antigen assessment by IHC. All test results and observed clinical signs 15 
reported by the veterinarians were gathered in a databank at the INSA. The following pathogens 16 
were tested: Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, B. hyodysenteriae, E. 17 
coli, H. parasuis, M. hyopneumoniae, M. hyorhinis, P. multocida, PCV-2, PRRSV, Salmonella 18 
ssp., Staphylococcus aureus, S. suis with serotype identification, SIV, and a few others in very 19 
rare occasions (e.g., Rotaviruses, Klebsiella ssp., Lactobacillus ssp., and Pasteurella ssp.). A 20 
total of 121 cases submitted between October 2006 and January 2007 were selected based on the 21 
results of the PCV-2 mrtqPCR. In these cases, a positive mrtqPCR result was recorded for at 22 
least one of the 2–3 submitted live animals or carcasses, all of which were examined and tested 23 
9 
individually. All pigs submitted for a case originated from the same farm and had the same age, 1 
which ranged between 3 and 15 weeks. In the selected population of PCVAD compatible 2 
(PCVAD/c) cases, 40.5% had the highest PCVAD/c rank and showed moderate to severe signs 3 
of wasting or weight loss, dyspnea, coughing, pallor, and jaundice, with characteristic 4 
histopathological lesions such as  multifocal lymphohistiocytic pneumonia, lymphocytic 5 
depletion, and multinucleated giant cell formation. An additional 40.5% of cases had the lowest 6 
PCVAD/c rank and showed neither clinical signs nor histopathological lesion (Table 1). Among 7 
the 121 PCVAD/c cases, 42 had their PCVAD status confirmed by IHC testing and 79 were IHC 8 
untested. In addition, the PRRSV and PCV-2 PCR quantification results were included in the 9 
databank generated for statistical analysis. The quantification of PCV-2 was determined with the 10 
mrtqPCR by comparing the sample results with a standard curve based on the amount of serially 11 
diluted PCV-2 recombinant plasmids (pCR2.1/PCV-2a and pCR2.1/PCV-2b). Moreover, the 12 
probe that could identify all PCV-2 genotypes (Circo-Gen-Probe) was also used to quantify 13 
PCV-2 in submitted samples. The PCV-2 quantification results were reported as the number of 14 
DNA copies/gram of tissue. A PRRSV real-time PCR diagnostic kith specific for the North 15 
American genotype of PRRSV was used for PRRSV identification as recommended by the 16 
manufacturer. The quantification of PRRSV was determined with the kit by comparing the 17 
sample results with a standard curve based on the amount of serially diluted IAF-Klop PRRSV 18 
reference strain22 titrate following infection of MARC-145 cells and expressed as TCID50/mL. 19 
The PRRSV quantification results were reported as the number of TCID50/gram of tissue. The 20 
amount of PCV-2 and PRRSV in each case was established by calculating the mean value of 21 
virus quantification of positive animals. The IHC assay was performed as previously described53 22 
using an anti-PCV-2 rabbit polyclonal serum (kindly provided to the MAPAQ by Dr Dave 23 
10 
Cavanaugh, Iowa State University). A case was considered IHC positive if tissue (lung or lymph 1 
nodes) of at least one of its submitted animals gave a positive result. 2 
Statistical analyses were performed with the SAS system, version 9.1.i The relevance of 3 
the PCVAD/c score system was evaluated by establishing its statistical relationship with the 4 
PCV-2 IHC test using the Mantel-Haenszel χ² test. Afterwards, the association between the 5 
PCVAD/c score system and the presence of PRRSV was established with a likelihood ratio χ² 6 
test; separate univariate logistic regressions were performed to test its relationship with the 7 
logarithms of the PCV-2 and PRRSV viral loads (PCV-2/vl and PRRSV/vl, respectively), which 8 
were expressed in DNA copies/gram of tissue and TCID50/gram of tissue, respectively. In 9 
addition, Kruskal-Wallis non-parametric tests were performed to detect differences in PCV-2/vl 10 
as a function of IHC result (untested, negative and positive) in each of the 4 PCVAD/c score 11 
levels. This series of tests were performed at the α = 0.0125 level (i.e., Bonferroni adjustment) to 12 
set the overall type-1 error risk at 0.05. Then, a multivariate polytomous logistic regression2,31 13 
was performed to examine the concurrent effects on the PCVAD/c score of the following 14 
variables: 1) the PCV-2/vl, 2) the presence of PRRSV, 3) the PRRSV/vl, 4) IHC testing, 5) IHC 15 
result, and 6) all possible interactions of these predictor variables. Inclusion of two IHC-related 16 
variables allowed comparing the differences in PCVAD/c score of the two subgroups, and 17 
assessing the potential redundancy of the mrtqPCR with respect to IHC, which is a key 18 
diagnostic criterion.51 The reference outcome value of the PCVAD/c score was set to 0 to focus 19 
on variation from clinical normality, and the cumulative logit function was used as a link 20 
between the predictors and response variables. The statistical model was built by stepwise-21 
forward selection of the predictors, where marginal P-value thresholds of 0.15 and 0.20 were 22 
used, respectively, for introducing a predictor in the model or deleting it from the model.31 The 23 
11 
likelihood ratio test was performed at each step to evaluate the significance of the newly added 1 
predictor. The score test for the proportional odds assumptioni was used to verify that the 2 
proportional odds model39 was valid for analyzing the ordinal response variable. In addition, the 3 
authors dichotomized among the levels of the PCVAD/c score system (i.e., between 0 and ≥1, 4 
between ≤1 and ≥2, etc.) and performed separate binary logistic regressions to further investigate 5 
the validity of the proportional odds assumption.3 Once the best logistic regression model was 6 
obtained, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated for each 7 
significant predictor or interaction of predictors.31 Afterwards, a series of binary logistic 8 
regressions was performed to determine the odds of recovering the above listed viral and 9 
bacterial pathogens as a function of the PCVAD/c score, the PCV-2/vl, the presence of PRRSV, 10 
and the PRRSV/vl. Relevant predictors and interactions were introduced in the model using the 11 





Identification of the ORF2 hypervariable region by sequence analysis 2 
Based on sequence analysis of 125 PCV-2 strains (46 PCV-2a strains and 79 PCV-2b 3 
strains), the ORF2 gene was identified to be the most variable gene between both PCV-2 4 
genotypes, as previously described by the authors and others.23,24 Consequently, the 5 
hypervariable region of ORF2 was targeted to differentiate both PCV-2 genotypes. The 6 
hypervariable region of ORF2 was localized between nucleotides (nt) position 222 and 279 from 7 
the gene start codon (data not shown). In the hypervariable region, 20 nt over 57 are different 8 
between both genotypes, which represents overall 35% nt variation in this region (data not 9 
shown). Because the 3’end hypervariable region is more conserved than the 5’end nt sequence 10 
within PCV-2a strains, the 3’end region was selected to design DNA probes that could 11 
differentiate genotypes and quantify PCV-2 viruses (data not shown). 12 
Sensitivity of Porcine circovirus-2 primers and probes 13 
To compare the sensitivity of the mrtqPCR with that of a conventional mPCR (an assay 14 
designed to differentiate PCV-1 from PCV-2 viruses but not between PCV-2 genotypes),46 serial 15 
10-fold dilutions of PCV-2b FMV-06-1717 and PCV-2a IAF2897 infectious isolates were tested 16 
with both assays (Fig. 1). The mrtqPCR was determined to be at least 1000-fold more sensitive 17 
than the mPCR (Fig. 1). The mrtqPCR standard curves were generated for both genotypes with 18 
10-fold dilutions of quantified recombinant DNA (Fig. 2c). The coefficients of determination 19 
(R2) were over 0.99 for all the regression of the standard curves. By using the cycle threshold 20 
(Ct) values and the regression equations of those standard curves, the DNA copy number 21 
detected was calculated for each positive mrtqPCR reaction with a detection limit estimated to be 22 
25 DNA viral genome copies/mrtqPCR reaction for all primers and probes sets (data not shown) 23 
13 
because a non-reproducible detection of PCV-2 recombinant DNA could be observed below this 1 
value. The Ct value obtained at 25 DNA viral genome copies/mrtqPCR reaction was 37. All 2 
results with a Ct value greater than 37 were considered to be negative for PCV-2. Moreover, 3 
when the mrtqPCR was compared with a previously described PCV-2 real-time PCR assay that 4 
could not differentiate PCV-2 genotypes,23 the sensitivity of both real-time PCR assays was 5 
similar for all mrtqPCR primers and probes sets (data not shown). 6 
Two types of targets, recombinant DNA and purified viral DNA, were used to evaluate 7 
the PCV-2 quantification efficiency of the mrtqPCR assay. From an initial concentration of 8 
pCR2.1/PCV-2b recombinant plasmid corresponding to 1.0×1010 PCV-2 viral genome 9 
copies/mL, 10-fold serial dilutions were made and tested by mrtqPCR. At the same time, the 10 
FMV-06-1717 PCV-2 infectious virus (4.7×103 TCID50/mL) was serially diluted and DNA was 11 
subsequently extracted from each dilution and tested with the mrtqPCR assay. Interestingly, the 12 
mrtqPCR standard curves obtained with the 2 different templates (recombinant DNA and 13 
purified viral DNA) were parallel with almost the same slope (Fig. 3). This indicates a very good 14 
correlation between the mrtqPCR quantification using both templates. For each time point, a 106-15 
fold difference was consistently observed in the mrtqPCR using the 2 different templates. 16 
Overall, similar results were obtained when the mrtqPCR was performed with the pCR2.1/PCV-17 
2a recombinant purified DNA compared to DNA purified from IAF 2897 infectious PCV-2a 18 
isolate (data not shown). The mrtqPCR appears to be more sensitive than the culture of infectious 19 
virus, as the limit of detection of the technique is under a single TCID50 (Fig. 3). 20 
Specificity and differentiation capacity of the multiplex real-time quantitative polymerase 21 
chain reaction 22 
14 
From a panel of RNA and DNA extracted from bacterial and viral cultures, serum, and 1 
tissues, only the samples containing PCV-2 were positive by mrtqPCR (data not shown). As 2 
illustrated in Figures 2a and 2b, the mrtqPCR assay detected specifically each genotype. Also, 3 
when recombinant DNA of both genotypes was mixed together, the mrtqPCR assay was able to 4 
identify both genotypes simultaneously (Fig. 2c). 5 
Retrospective epidemiological survey 6 
Examination of the clinical samples (lungs and lymph nodes) from the authors’ databank 7 
of 121 cases originating from different farms revealed that 92.56%, 4.13%, and 3.31% cases 8 
were positive for PCV-2b genotype alone, PCV-2a genotype alone, and both genotypes, 9 
respectively (Table 2). This latter result indicates the existence of PCV-2 mixed infections in 10 
Quebec swine herds, but the number of PCV-2a submitted cases recovered was too low to be 11 
able to determine whether the PCVAD/c score is affected significantly by the genotype of PCV-2 12 
that was involved as illustrated in Table 2 by the prevalence of PCV-2 genotypes in regards to 13 
PCVAD/c status.  14 
The PCVAD/c score was linearly associated with the result of the PCV-2 IHC assay 15 
(Mantel-Haenszel χ²; P < 0.0001), as an average of 93% (14/15) of cases with a score ≤1 came 16 
out negative, whereas an average of 81% (22/27) of cases with a score ≥2 were positive (Fig. 4a). 17 
This confirmed the validity of the PCVAD/c score system. In each PCVAD/c score grade, no 18 
significant difference in PCV-2/vl was recorded for the IHC untested and IHC tested cases 19 
(Kruskal-Wallis tests; P > 0.25). In the case of PCVAD/c score = 0, the median PCV-2/vl value 20 
was 5.7735 for the IHC untested cases, and 6.8348 for the IHC negative cases. In the case of 21 
PCVAD/c score = 3, the median PCV-2/vl value was 10.6821 for the IHC untested cases, and 22 
10.3729 for the IHC positive cases. These results strongly suggest that the IHC untested cases 23 
15 
with a PCVAD/c score value of 0 are true negative PCVAD cases, and those with a score value 1 
of 3 are true positives PCVAD cases. 2 
The univariate logistic regression analysis indicated that the value of the PCVAD/c score 3 
was significantly affected by the PCV-2/vl (P < 0.0001). To support this result, the mrtqPCR Ct 4 
mean values obtained were 30.31, 27.41, 19.74, and 15.54 for PCVAD/c grade score 0, 1, 2, and 5 
3, respectively. Furthermore, this result is clearly illustrated in Figure 4a where a higher amount 6 
of PCV-2 correlated with a higher PCVAD/c grade score. In addition, the PCVAD/c score was 7 
significantly affected by the presence of PRRSV (likelihood ratio χ²; P = 0.0258), as well as by 8 
the PRRSV/vl (univariate logistic regression; P = 0.0249), which granted further evaluation with 9 
the multivariate polytomous logistic regression. 10 
This polytomous logistic regression for ordinal data, which simultaneously takes into 11 
account the above listed variables and their interactions, revealed that the level of PCVAD/c 12 
score was significantly affected by the PCV-2/vl (P = 0.0161) and by the result of the IHC assay 13 
(P = 0.0128). In addition, a significant interaction between the results of the IHC assay and the 14 
PCV-2/vl (P = 0.0304) was recorded. But the PCVAD/c score was significantly affected neither 15 
by IHC testing (untested vs. tested; P=0.3502), nor by the presence of PRRSV and PRRSV/vl (P 16 
> 0.9; Fig. 4b). The coefficient estimates of the final model (data not shown) revealed that IHC 17 
and PCV-2/vl considerably decreased the odds of a null score. The odds ratios of having a 18 
PCVAD/c score greater than 0 following PCV-2 PCR quantification and IHC testing are 19 
presented in Table 3. A positive IHC result increased the odds ratio of having a PCVAD/c score 20 
greater than 0 by 3.52×104 (Table 3). Furthermore, the PCV-2 quantification (PCV-2/vl) 21 
increased the odds ratio of having a PCVAD/c score greater than 0 by 4.08 with a PCV-2/vl log-22 
scale unit increase (Table 3). Interestingly, both variables (IHC-positive result and PCV-2/vl) 23 
16 
increased the odds ratio of having a PCVAD/c score greater than 0 by 5.45×104 per PCV-2/vl 1 
log-scale unit increase (Table 3). 2 
Table 4 presents the effects of the PCVAD/c score, the PCV-2/vl, the presence of 3 
PRRSV, and the PRRSV/vl on the odds of recovering a number of swine pathogens from 4 
samples of a given case from the authors’ databank. The prevalence of those pathogens in 5 
regards to the PCVAD/c grade score 0 and 3 (which are considered to be non-PCVAD and 6 
PCVAD cases, respectively, based on Kruskal-Wallis and multivariate polytomous logistic 7 
regression analyses) are also given in Table 4. None of these variables (PCVAD/c score, the 8 
PCV-2/vl, the presence of PRRSV, and the PRRSV/vl) had significant effect on the odds of 9 
isolating A. pyogenes, B. hyodysenteriae, S. hyicus, or SIV (P > 0.20 in all cases). From the 10 
predictors tested, the PCV-2 viral load (i.e., PCV-2/vl) was found a risk factor for 2 pathogens 11 
and the PRRSV viral load (i.e., PRRSV/vl) was found a risk factor for 5 pathogens. The PCV-12 
2/vl significantly increased the risk of recovering A. pleuropneumoniae (OR = 1.887) and S. suis 13 
serotypes 1/2, 1, 2, 3, 4 and 7, which are serotypes commonly associated with clinical diseases29 14 
(S. suis pathogenic serotypes; OR = 1.3690). In contrast, PCV-2/vl had no significant effect on 15 
the odds of isolating S. suis when all of its serotypes were included (i.e., generic S. suis). The 16 
odds of isolating M. hyopneumoniae were significantly higher in pigs with a PCVAD/c score of 17 
2, compared to the reference population with a PCVAD/c score of 0 (OR = 7.800). Nevertheless, 18 
PCV-2 had null or significantly negative effect on the risk of recovering other pathogens, 19 
especially B. bronchiseptica, E. coli, and Salmonella spp. On the contrary, PRRSV significantly 20 
increased the risk of recovering B. bronchiseptica, E. coli, H. parasuis, P. multocida, and generic 21 
S. suis (PRRSV/vl; OR = 1.305, 1.479, 1.443, 1.474, and 1.203, respectively). In 2 cases, the 22 
17 
PCV-2 viral load had opposite sign coefficients compared to PRRSV viral load, suggesting that 1 
their combined effect was not additive. 2 
 3 
Discussion 4 
One of the main objectives of the swine industry and health scientists is to establish if 5 
there is virulence variation between PCV-2a and PCV-2b viruses. In fact, a recent retrospective 6 
study5 showed a statistically significant increase in the frequency of PCVAD characteristic 7 
histological lesions observed in lymph node, spleen, lung, small intestine, colon, and kidney, in 8 
pigs infected with PCV-2b strains, compared to pigs infected with PCV-2a strains. Viral burden, 9 
as estimated with IHC staining in lymph node, was also significantly increased in pigs infected 10 
with the PCV-2b strains, compared to the PCV-2a strains.5 Because these results were derived 11 
from retrospective analysis of cases submitted to diagnostic laboratories, the conclusion may be 12 
biased. Nonetheless, it strongly suggests that PCV-2b virus could be more virulent than PCV-2a 13 
virus. Moreover, others have reported that genetic variations may have a great impact on the 14 
virulence of PCV-2.21 Consequently, it became critical for swine producers and veterinarians to 15 
establish which PCV-2 genotypes are present in their herds. In that context, an mrtqPCR assay 16 
was developed to sensitively identify and differentiate PCV-2 viruses in clinical samples (Figs. 17 
1, 2; Table 2). With the exception of the conventional PCR assay developed previously,30 all 18 
other PCR assays reported until now did not differentiate between PCV-2 genotypes.4,12,34,55 19 
Moreover, the conventional PCR diagnostic test reported previously30 required 2 PCR reactions 20 
to identify both genotypes whereas only 1 reaction is required in the authors’ mrtqPCR. 21 
Furthermore, real-time PCR assays are usually more sensitive than conventional PCR assays as 22 
illustrated in Figure 1. 23 
18 
Interestingly, a good correlation was established with the mrtqPCR assay between 2 1 
quantification methods, the DNA copies/mL versus the TCID50/mL (Fig. 3). The relationship 2 
between the 2 PCV-2 quantification methods (DNA copies vs. infectious virus) was determined 3 
to be: DNA copies/mL value = (1.76×106) × TCID50/mL value (Fig. 3). It is unknown whether 4 
this equation could be generalized to all PCV-2 isolates, since new recombination or mutations 5 
of the viral genome within the mrtqPCR targeted regions could interfere with both quantification 6 
and genotyping results. Furthermore, PCR inhibitors in clinical specimens could adversely affect 7 
the PCV-2 quantification. Nonetheless, it will help veterinarians in their interpretation of the 8 
diagnostic results obtained with the mrtqPCR assay. 9 
The standard PCVAD definition consists in three criteria: 1) presence of characteristic 10 
clinical signs, 2) presence of characteristic histopathological lesions in lymphoid tissues, and 3) 11 
detection of moderate to high amount of PCV-2 within the lesions in lymphoid and other tissues 12 
by different techniques such as IHC. In order to statistically test the respective roles of PCV-2 13 
viral load and the result of IHC testing in regards to the PCVAD status of the clinical cases, it 14 
was purposely decided not to apply the above definition.51 Specifically, the third criterion was 15 
omitted in the PCVAD case definition as detailed in Table 1. Noteworthy, both the Kruskal-16 
Wallis and multivariate polytomous logistic regression analyses revealed that at identical PCV-17 
2/vl values, the IHC untested cases had similar PCVAD/c score grades compared to IHC 18 
negatives and positives cases. Consequently, these results indicated that the PCVAD/c grade 0 19 
and 3 cases are not significantly different from their IHC-tested counterparts (standard negative 20 
and positive PCVAD cases), and strongly suggests that both groups are identical. 21 
A very strong logistic (sigmoid) relationship was recorded between the PCVAD/c grade 22 
score and the result of IHC assay, as well as the logarithm of the amount of PCV-2 virus 23 
19 
recovered from the tissue samples using the mrtqPCR assay and the interaction between these 2 1 
independent variables (Fig. 4a). Interestingly, the stepwise-forward logistic regression analysis 2 
suggests that the PCV-2 viral load may be a reliable alternative to the IHC assay as the third 3 
criterion of the PCVAD definition since at PCVAD/c grade 3 score, the lowest amount of PCV-2 4 
detected was 107.5 DNA copies/gram of tissue, at which the OR of having PCVAD/c was 5 
established to be 1/e(-1.4057×7.5) = 3.79×104 (95% C.I. = 1/e(-1.4057×7.5 ± 1.96×7.5×0.2180) = [1.53×103 – 6 
9.34×105]), which favorably compares to the OR and 95% C.I. of a positive IHC result (Table 3, 7 
scenario #2). Moreover, with the median PCV-2/vl value of the grade-3 score, the resulting OR 8 
and 95% C.I. are 3.11×106 and [3.31×104 – 2.93×108], respectively. These results are not 9 
surprising because PCR has been shown to be more sensitive than IHC.  Indeed, other 10 
investigators have reported that from 20 PCV-2 experimentally infected pigs, 0% were PCR-11 
negative but 5% were IHC-negative when testing lymph nodes, and 10% were PCR-negative but 12 
44% were IHC-negative when testing the lung tissue.32 Furthermore, from 88 pigs tested in a 13 
commercial herd with severe PMWS, only 3% were PCR-negative but 23% were IHC-14 
negative.40 The latter result is similar to our findings, as 4 of the 19 (21%) cases with PCVAD/c 15 
score = 3 were IHC negative despite showing high PCV-2 viral load at the mrtqPCR testing. 16 
This relationship between PCV-2 viral load and clinical expression of PCVAD confirms 17 
results previously reported.4,44 Consequently, the higher the PCV-2 viral load in tissue samples, 18 
the higher the probability to have PCVAD (Fig. 4a). This remains a probability since a high 19 
amount of PCV-2 viral load has been observed in some cases unrelated to PCVAD and vice 20 
versa (Fig. 4a). Surprisingly, the stepwise-forward logistic regression analysis revealed that a 21 
positive IHC result significantly increased the odds of clinical disease, even if PCV-2 viral load 22 
is already present in the model (Table 3). These results suggest that PCV-2 viral load and IHC 23 
20 
testing may represent 2 separate components of the overall disease process, but their statistically 1 
independent biological meaning could not be determined within the retrospective study. 2 
In the present study, the prevalence of PCV-2b virus was very high as previously 3 
reported.23 In fact, 95.9% of the submitted cases were infected with PCV-2b virus (Table 2), 4 
even though 40.5% of those submitted cases had no clinical sign and microscopic lesion related 5 
to PCVAD. This suggests that not all animals infected with PCV-2b virus may develop PCVAD. 6 
However, the difference observed between the presence of PCVAD and the number of PCV-2b 7 
cases may be due to the stage and time course of infection when the tissue samples were 8 
collected. As reported previously,30 PCV-2a and -2b mixed infections were also observed but at a 9 
lower prevalence in Quebec province (3.31%) compared to that in a Kansas study (62.5%). The 10 
difference between prevalence values could be due to specimen origin because samples were 11 
obtained from pigs experiencing severe PCVAD in the Kansas study,30 whereas in the present 12 
study almost half of samples were obtained from animals that had no PCVAD clinical signs 13 
(Table 1). Nonetheless, even if the disease evolution following PCV-2 mixed infections is 14 
unknown, it may have an effect since recombination between PCV-2 genomes has been 15 
reported.28,37,43 16 
The course of PCV-2 infection that will lead to the occurrence of the disease has been 17 
associated with the presence of others pathogens such as M. hyopneumoniae, Porcine parvovirus 18 
(PPV), PRRSV, and SIV.16,18,45,48 Thus, it was not surprising to find at the preliminary stage of 19 
data analysis, that a significant association existed between the presence of PRRSV and the 20 
appearance of PCVAD, as previously reported. Similar to the correlation between PCV-2 viral 21 
load and PCVAD/c (Fig. 4a), there was a significant association between PRRSV viral load and 22 
the appearance of PCVAD. In contrast, the multivariate polytomous logistic regression analysis 23 
21 
suggested that the presence and viral load of PRRSV had no significant effect on the PCVAD/c 1 
score, as shown in Figure 4b, when both PCV-2 viral load and IHC result parameters are 2 
included in the regression model. This suggests that PRRSV may be less involved as a cofactor 3 
responsible for the induction of PCVAD than expected.18,48 Indeed, animals with PCVAD may 4 
be PRRSV negative or have PRRSV low titers (Fig. 4b). In contrast, animals that have no 5 
PCVAD may possess a high viral load of PRRSV (Fig. 4b). Because of bias inherent to a 6 
retrospective epidemiological survey, caution must be taken in the interpretation of these results. 7 
In contrast to what has been reported previously,16 epidemiological assessment of the OR 8 
of PCV-2 coinfection with other swine pathogens in the present study did not involve SIV as an 9 
important cofactor (Table 4). This could be explained by the fact that the number of SIV-positive 10 
cases was very low in this studied population. Interestingly, statistical analyses revealed a high 11 
odds ratio (OR = 7.800) of recovering M. hyopneumoniae in PCVAD/c grade 2 score animals, 12 
which represents animals with PCVAD-specific microscopic lesions without having PCVAD 13 
clinical signs (Tables 1, 4). In a previous report,16 a 3.77 OR of recovering M. hyopneumoniae 14 
was found in PCV-2–positive animals, irrespective of their PCVAD status. Surprisingly, no 15 
association was found in the present study between M. hyopneumoniae and PCVAD/c grade 3 16 
score, which corresponds to pigs that show PCVAD clinical signs with the presence of PCVAD-17 
specific histopathological lesions. Consequently, even if there is a good chance of identifying M. 18 
hyopneumoniae in PCV-2–positive animals, the present study did not involve M. hyopneumoniae 19 
in animals that have clinical signs related to PCVAD (Table 4). The most interesting finding was 20 
the significantly increased odds ratios of isolating 2 major porcine respiratory pathogenic 21 
bacteria, A. pleuropneumoniae and S. suis pathogenic serotypes, as PCV-2 viral load increases 22 
(Table 4). As opposed to previous studies,16 the present study did distinguish between serotypes 23 
22 
of S. suis. Herein, association with PCV-2/vl was significant only for the pathogenic serotypes of 1 
S. suis (Table 4). Yet, despite a good statistical relationship between A. pleuropneumoniae, S. 2 
suis pathogenic serotypes, and PCV-2 viral load, it is impossible to determine if those bacterial 3 
pathogens increased the risk of PCVAD development or if they colonized the host respiratory 4 
tract following PCV-2 infection. 5 
In conclusion, the new mrtqPCR diagnostic assay is suitable for the sensitive 6 
identification and differentiation of PCV-2 and is a more convenient approach than RFLP, partial 7 
or entire viral genome sequencing, and conventional PCR techniques.6,23,30 Furthermore, it could 8 
efficiently quantify PCV-2 in submitted samples and provide a risk assessment in regards to the 9 
odds of developing PCVAD (Fig. 4a). Until now, it was believed that PRRSV played a major 10 
role in PCVAD development, and experimental infections with both pathogens (PRRSV and 11 
PCV-2) may confirm that.50 Nevertheless, if there is apparent statistical relationship with 12 
PCVAD and PRRSV in the present report, the impact of PRRSV in regards to PCVAD seems 13 
negligible, as previously reported,52 when statistical analysis takes into account other relevant 14 
variables like the PCV-2 viral load. Since the odds of isolating A. pleuropneumoniae and 15 
pathogenic S. suis is significantly higher when the PCV-2 viral load increases, new experiments 16 
are now being conducted to evaluate the impact of PCV-2 and the mechanisms involved on the 17 
bacterial colonization of the swine respiratory tract. 18 
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Table 1. Design of the Porcine circovirus-associated disease compatible (PCVAD/c) score and 1 
distribution of clinical cases in the score system. 2 
PCVAD/c 
score PCVAD clinical signs PCVAD histopathological lesions No. of cases Percentage 
0 No No 49 40.50 
1 Yes No 5 4.13 
2 No Yes 18 14.87 
3 Yes Yes 49 40.50 
3 
31 
Table 2. Porcine circovirus-2 (PCV-2) genotype classification results based on the new 1 
multiplex real-time quantitative polymerase chain reaction assay and their prevalence in Porcine 2 
circovirus-associated disease compatible (PCVAD/c) and non compatible cases.* 3 
Genotype classification Total no. of cases 
Distribution by PCVAD/c 
status 
Negative† Positive‡ 
PCV-2a 5 (4.13) 3 (60.00) 2 (40.00) 
PCV-2b 112 (92.56) 45 (40.18) 45 (40.18) 
PCV-2a and -2b 4 (3.31) 1 (25.00) 2 (50.00) 
Total 121 49 (40.50) 49 (40.50) 
* Numbers in parentheses are percentages. 4 
† Based on grade 0 PCVAD/c score (see Table 1). 5 
‡ Based on grade 3 PCVAD/c score (see Table 1). 6 
7 
32 
Table 3. Odds ratios of having a Porcine circovirus-associated disease compatible (PCVAD/c) 1 
score greater than zero, as a function of Porcine circovirus-2 (PCV-2) viral load, and result of 2 
immunohistochemistry (IHC) testing.*  3 





1 Negative With 1 log-scale unit increase 4.08 2.66–6.25 
2 Positive Without increase compared to reference case 3.52×104 2.72×101–4.57×107 
3 Positive With 1 log-scale unit increase 5.45×104 6.93×101–4.29×107 
* PCV-2/vl = logarithm of Porcine circovirus-2 viral load. Odds ratios were determined using 4 
the following reference case: negative IHC result and PCV-2/vl equal 0. 5 
6 
33 
Table 4. Type of effect and statistical significance of the Porcine circovirus-associated disease 1 
compatible (PCVAD/c) score, Porcine circovirus-2 (PCV-2) viral load, and the presence and 2 
viral load of Porcine respiratory and reproductive syndrome virus (PRRSV) on the odds of 3 








Odds ratio† (P-value, type-3 analysis) 
PCVAD‡ PCV-2/vl PRRSV PRRSV/vl 
Actinobacillus 
pleuropneumoniae 
8.16/0 0.0112 NS 1.887 
(0,0583) 
NS NS 
Arcanobacterium pyogenes 12.24/18.37 NS NS NS NS NS 




Brachyspira hyodysenteriae 2.04/6.12 NS NS NS NS NS 






Haemophilus parasuis 24.49/24.49 0.0052 NS NS NS 1.443 
(0.0065) 
Mycoplasma hyopneumoniae 6.12/10.20 0.0088 7.800 
(0,0127)§ 
NS NS NS 
Pasteurella multocida 42.86/34.69 0.0009 NS NS NS 1.474 
(0,0014) 
Salmonella spp. 2.04/6.12 0.1085 NS 0.672 
(0,1568) 
NS NS 
Staphylococcus hyicus 12.24/18.37 NS NS NS NS NS 
Streptococcus suis       
All serotypes 63.27/53.06 0.1085 NS NS NS 1.203 
(0,1131) 
Pathogenic serotypes¦ 67.74/37.04 0.0172 NS 1.369 
(0,0223) 
NS NS 
Swine influenza virus 12.24/8.16 NS NS NS NS NS 
* NS = nonsignificant; PCV-2/vl = logarithm of Porcine circovirus-2 viral load; PRRSV/vl = 5 
logarithm of Porcine reproductive and respiratory syndrome virus viral load. 6 
† Odds ratio values lower than 1 indicate decreased risk of isolation and values greater than 1 7 
indicate increased risk of isolation. 8 
‡ Statistical association was made with the PCVAD/c grade score as described in Table 1. 9 
§ A significant odds ratio to recover Mycoplasma hyopneumoniae was made only with 10 
PCVAD/c grade score of 2. 11 
¦ Streptococcus suis pathogenic serotypes (1/2, 1, 2, 3, 4, and 7) commonly associated with 12 
clinical disease. 13 
14 
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Figure legends 1 
Figure 1. Comparison of the sensitivity of the multiplex real-time quantitative polymerase chain 2 
reaction (mrtqPCR) assay to that of a conventional multiplex PCR assay (mPCR). Ten-fold serial 3 
dilutions of Porcine circovirus-2 genotypes 2a and 2b (PCV-2a [strain IAF 2897] and -2b [strain 4 
FMV-06-1717]) were used as templates in the mrtqPCR and mPCR assays. The R2 curve values 5 
are indicated next to their corresponding curve in the figure. The mPCR was carried out as 6 
previously reported.44 The mrtqPCR and mPCR assays were done in triplicate and similar results 7 
were obtained. Therefore, to improve the clarity of the figure, standard deviation results have 8 
been omitted. Ct = threshold cycle value obtained with the mrtqPCR assay; mrtqPCR PCV-2a 9 
(◊) = PCR results obtained with the Circo-2a-Probe; mrtqPCR PCV-2b (∆) = PCR results 10 
obtained with the Circo-2b-Probe. 11 
Figure 2. Differentiation of Porcine circovirus-2 (PCV-2) genotypes by the multiplex real-time 12 
quantitative polymerase chain reaction (mrtqPCR) assay. Ten-fold serial dilutions of PCV-2 13 
recombinant plasmids (pCR2.1/PCV-2a and pCR2.1/PCV-2b) were used as templates in the 14 
mrtqPCR assay. The R2 curve values are indicated next to their corresponding curve in the 15 
figure. A, pCR2.1/PCV-2a was used as template. Negative results (>37 Ct) were obtained for 16 
PCV-2b detection. B, pCR2.1/PCV-2b was used as template. Negative results (>37 Ct) were 17 
obtained for PCV-2a detection. C, both pCR2.1/PCV-2a and pCR2.1/PCV-2b were used as 18 
template. The mrtqPCR assay was done in triplicate and similar results were obtained. Therefore, 19 
to improve the clarity of the figure, standard deviation results have been omitted. Ct = threshold 20 
cycle value obtained with the mrtqPCR assay; PCV-2 Gen (×) = PCR results obtained with the 21 
Circo-Gen-Probe; PCV-2a (∆) = PCR results obtained with the Circo-2a-Probe; PCV-2b ( ) = 22 
PCR results obtained with the Circo-2b-Probe. 23 
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Figure 3. Porcine circovirus-2 (PCV-2) quantification: infectious particles versus DNA viral 1 
genome copies. Ten-fold serial dilutions of known amounts of PCV-2b reference virus (FMV-2 
06-1717) and of PCV-2b recombinant plasmid (pCR2.1/PCV-2b) were used as DNA templates 3 
in the multiplex real-time quantitative polymerase chain reaction (mrtqPCR) assay. The amount 4 
of PCV-2b virus was expressed in TCID50/mL and the amount of pCR2.1/PCV-2b was 5 
expressed in number of DNA copies/mL. The R2 curve values and the equations of the curve are 6 
indicated next to their corresponding curve in the figure. The data obtained in regards to PCV-2a 7 
virus and recombinant PCV-2a plasmid were not shown since the curves were overlapping with 8 
those already present in the figure. Ct = threshold cycle value obtained with the mrtqPCR assay. 9 
Figure 4. Relationship between the logarithms of the Porcine circovirus-2 (PCV-2) and Porcine 10 
respiratory and reproductive syndrome virus (PRRSV) viral loads, and the Porcine circovirus-11 
associated disease compatible (PCVAD/c) grade score classification. A, the amount of PCV-2 12 
found in submitted tissues (lungs and lymph nodes) was evaluated using the multiplex real-time 13 
quantitative polymerase chain reaction (mrtqPCR) assay and was expressed as DNA copies/gram 14 
of tissue. B, the amount of PRRSV found in submitted tissues (lungs and lymph nodes) was 15 
evaluated using a PRRSV real-time PCR diagnostic kit,h as described in the materials and 16 
methods section of the manuscript, and was expressed in TCID50/gram of tissue. All PRRSV-17 
negative cases were not included in panel B. Moreover, each case submitted to the diagnostic 18 
laboratory was classified following their immunohistochemistry (IHC) results. PCV-2/vl = PCV-19 
2 viral load; PRRSV/vl = PRRSV viral load. (Note: to improve clarity, the cases with negative 20 
IHC results had their PCVAD/c scores shifted upwards by 0.06, and cases with positive IHC 21 
results had their PCVAD/c scores shifted upwards by 0.12.) 22 




